featured
news articles

Total number of categories

Total number of articles

Market/Novel Tech

Allergan acquires gene therapy company RetroSense Therapeutics LLC for $60M upfront cash.

Allergan plc. (NYSE:AGN), based in Dublin, Ireland, has announced the acquisition of Michigan-based gene therapy company RetroSense Therapeutics in an upfront all-cash based transaction for $60M.  As part of the transaction, Allergan has additionally agreed to the payment of further potential regulatory and commercialization milestone payments related to a lead development program, “RST-001”, an experimental […]

Read full story
Featured

Phase III data for 0.02%/0.005% netarsudil/latanoprost shows topline efficacy for lowering IOP in treatment of glaucoma.

Top-line efficacy data for the use of 0.02%/0.005% netarsudil/latanoprost (known as Roclatan) in lowering IOP has shown that the formulation achieved a primary efficacy endpoint of statistical superiority over each of its components alone. However, it remains unclear what proportion of patients obtained a clinically significant effect from the treatment. The Phase III study, named […]

Read full story
Research

Comprehensive survey suggests that eye disease and vision health ranks higher among medical concerns than loss of limbs, loss of memory and loss of hearing

A comprehensive public survey, commissioned by Research!America and supported by Research to Prevent Blindness and the Alliance for Eye and Vision Research, has found that respondents from all ethnic and racial groups consider blindness as “the worst ailment that could happen to them, relative to losing memory, speech, hearing, or a limb.” The survey, conducted […]

Read full story
Introduction

September 16th, 2016: “EURETINA-Brief”© Issue No. 140

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the September 16th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Featured

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story
Introduction

January 18th, 2016: “EURETINA-Brief”© Issue No. 125

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the January 18th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story

Latest News

Book Review